09/24/2013 - 10:22am

The global market for Type 2 diabetes will nearly double over the next six years, according to a new report.

09/11/2013 - 9:41am

Nearly all doctors say that the sharp growth in Type 2 diabetes around the world and the obesity epidemic are linked to excess sugar consumption, according to a new report by the Credit Suisse Research Institute.

09/10/2013 - 9:09am

Drug maker Depomed has expanded the geographic scope of a license agreement it has with Merck for diabetes drugs, the company said.

08/21/2013 - 12:34pm

The Food and Drug Administration has given the green light to an insulin pen made by Novo Nordisk for half-unit dosing, the drug maker said Wednesday.

08/20/2013 - 10:04am

A global population of patients with prediabetes that is three times the size of those who already have Type 2 diabetes has led to intense competition between drug makers to launch drugs to treat the disease, according to a new report.

08/02/2013 - 10:48am

Novo Nordisk is offering $80,000 to diabetes-education programs in a Minnesota city, the Danish drug maker said Friday.

07/30/2013 - 1:24pm

Some patients with Type 2 diabetes taking drugs to lower blood sugar may experience a greater drop than is healthy for them even though their disease may not be under control, according to a new study.

07/23/2013 - 10:53am

The Food and Drug Administration has approved a generic diabetes drug made by Lupin, the company said.

07/19/2013 - 9:29am

Perrigo announced the tentative approval for repaglinide tablets, a generic version of Novo Nordisk's Prandin, used to treat Type 2 diabetes.